Figure 7

Possible disturbed metabolic pathways of the potential biomarkers for atherosclerosis and AEE treatment. (a) Valine, leucine and isoleucine biosynthesis; (b) Glyoxylate and dicarboxylate metabolism; (c) Pantothenate and CoA biosynthesis; (d) Riboflavin metabolism; (e) Lysine degradation; (f) Nicotinate and nicotinamide metabolism; (g) Glycerophospholipid metabolism.